How do changes in tumor matrix affect the outcome of virotherapy? Research Abstract Details
Jump to the:
For similar therapeutics: biological therapy: oncolytic virotherapy research abstracts see: therapeutics: biological therapy: oncolytic virotherapy research
PUBMED ID PMID:
MEDLINE DATE:
PUBLICATION TYPE: Research Support, U.S. Gov't,
Journal: Cancer biology & therapy
VOLUME: 6
Page Numbers: 290-2
Journal Abbreviation:
ISSN: 1538-4047
DAY: 8
MONTH: 02
YEAR: 2007
Number of References:
LANGUAGE: eng
NlmUniqueID: 101137842
KEYWORDS: Oncolytic Virotherapy
MESH TERMS: therapy
Substance Name:
Registry Number:
AFFILIATION: Departments of Medicine & Pathology, NYU School of Medicine, 550 First Avenue, New York, NY 10016, USA.
Country: United States
AGENCY: United States NCI
GRANT: R01 CA 102053
ACRONYM: CA
MEDLINETA: Cancer Biol Ther
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!
Already registered? Login now below.
Already registered and Forgot your password? Click below to recover it.
Recover Lost Password
Join now - it's fast and free!
Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!
For more click here:Science News